US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.0865
- -0.0045-4.95%
Close May 7 16:00 ET
- 0.0880
- +0.0015+1.73%
Post 16:16 ET
3.12MMarket Cap-21P/E (TTM)
0.0939High0.0770Low15.08MVolume0.0915Open0.0910Pre Close1.45MTurnover42.02%Turnover RatioLossP/E (Static)36.06MShares1.280052wk High2.28P/B3.10MFloat Cap0.065052wk Low--Dividend TTM35.89MShs Float3718.7485Historical High--Div YieldTTM18.57%Amplitude0.0650Historical Low0.0950Avg Price1Lot Size
About NovaBay Pharmaceuticals Company
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Company Profile
SymbolNBY
Company NameNovaBay Pharmaceuticals
Listing DateOct 26, 2007
Issue Price4.00
Founded2000
CEOMr. Justin M. Hall
MarketAMEX
Employees26
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2000 Powell Street,Suite 1150
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608-1866
Phone1-510-899-8800
Websitehttp://www.novabay.com
Company Executives
- Name
- Position
- Salary
- Justin M. Hall
- Chief Executive Officer, Director, Chief Compliance Officer and General Counsel
- 364.15K
- Tommy Law
- Corporate Controller, Interim Chief Financial Officer and Treasurer
- 177.70K
- Paul E. Freiman, PhD
- Chairman of the Board
- 78.08K
- Mijia Wu, M.B.A.
- Director
- 40.58K
- Yongxiang Zheng
- Director
- 40.58K
- Julie Garlikov
- Independent Director
- 40.58K
- Swan Sit
- Independent Director
- 59.08K
- Dr. Yanyou Zheng, PhD
- Independent Director
- 74.08K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg